Skip to main content
OpenTrials
Completed

NCT Number: NCT05853848

Mammogram Mail- and Phone-based Interventions

The project aims to evaluate four different versions and modalities of interventions encouraging mammogram screening among all eligible women due or overdue for screening. The evaluation will compare among the following forms of outreach to help determine whether (a) live calls are more effective at increasing mammogram screening than other forms of outreach and (b) each form of outreach is more effective than no outreach: (1) a postcard, (2) a letter, (3) an auto-dialer phone message, and (4) a live call from a care gaps team. The interventions will be rolled out over many months, allowing for comparisons of effectiveness against those who have not yet been contacted.

Completed

Looking for future studies?

Notify Me

Key information

Age range

51 year–74 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Geisinger

Danville, Pennsylvania, 17822, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female Geisinger Health Plan members between ages 52 and 74 as of December 31, 2023
  • Overdue for annual mammogram
  • Continuously enrolled with the Geisinger Health Plan as of October 1, 2021
  • Can be contacted via both phone and mail

Exclusion criteria

  • Geisinger Health Plan members on a do-not-contact list
  • Had a mammogram as of October 1, 2021
  • In hospice, using hospice services, or receiving palliative care as of January 1, 2023
  • Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness
  • Had a bilateral mastectomy at any time

Treatment and study plan

Postcard

Behavioral

Postcard with phone number to call for help scheduling a mammogram.

Letter

Behavioral

Letter with phone number to call for help scheduling a mammogram.

Auto-dialer

Behavioral

Auto-dialer with option to press button for help scheduling a mammogram.

Live call

Behavioral

Live call offering help scheduling a mammogram.

Primary outcomes

  1. Mammogram completed

    Time frame: In the 180 days following the patient's intervention send date

    Record of completed mammogram (yes/no), for comparing postcards, letters, and auto-dialer messages with live calls

  2. Mammogram completed

    Time frame: In the 120 days following the patient's intervention send date

    Record of completed mammogram (yes/no), for comparing postcards, letters, auto-dialer messages, and live calls with controls

Other outcomes

  1. Mammogram completed

    Time frame: In the 180 days following the patient's intervention send date

    Record of completed mammogram (yes/no), for comparing across postcards, letters, and auto-dialer messages

  2. Breast malignancy risk detected

    Time frame: In the 210 days following the patient's intervention send date

    Record of high malignancy risk (yes/no), for comparing across different modalities of outreach

  3. Mammogram appointment scheduled

    Time frame: In the 30 days following the patient's intervention send date

    Appointment scheduled for mammogram, among patients visiting Geisinger clinics (yes/no)

Sponsors and collaborators

Lead sponsor

Geisinger Clinic

Other

Registry information

Official study title

Randomized Comparison of Mail- and Phone-based Interventions Promoting Mammogram Screening

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
May 11, 2023
Registry last updated
Oct 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.